
Cellularis Biomodels develops bioengineered 3D in vitro tumor models for preclinical testing of candidate therapies.
cellularisbiomodels.comCrawled Oct 9, 2026
The RoadMap to Improve Drug Discovery 3D In Vitro Models The technological advancement and the consequent emerging of 3D models offer more opportunities for pre-clinical therapies screening, in a way…
Get Started with SUPRaDrop® Plates High-Throughput 3D Cell Culture Solutions Technology: Superhydrophobic surface designed to support the formation of uniform spherical microdroplets for droplet-based cell culture. Applications: Optimized for advanced…
Cellularis filed world patent on Physiomimetic Pancreatic Tumor-Stroma Models Cellularis Biomodels files its first international patent request focusing on the bioengineering of physiomimetic 3D In vitro tumor models recapitulating cancer-stroma…
Cellularis Breast Cancer models including decellularized extracellular matrix and cancer-stroma microenvironment elements for organotypic drug screening. Share via: More
Latest news from Cellularis Bimodels 3D human disease models company
Scientific Publications Advances in bioengineering pancreatic tumor-stroma physiomimetic Biomodels Biomaterials, 2022 | Monteiro, M. V., Ferreira, L. P., Rocha, M., Gaspar, V. M., & Mano, J.F. Advancing tissue decellularized hydrogels…
About CELLULARIS We are a deep-tech company that provides state-of-the-art 3D of human disease for the discovery of new biological targets and screening candidate therapies in the preclinical phase.…
Cellularis Biomodels is a biotechnology startup dedicated to the research and development of in vitro 3D tumor models to test candidate therapies in a pre-clinical phase, by using advanced bioengineering technologies and analytical tools.